# US 2026/0168497 A1 · Device to assist the performance of a heart

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0168497 A1
- Document ID: US20260168497A1
- Status: Published application
- Kind: A1
- Application number: 19/535,420
- Filed: 2026-02-10
- Published: 2026-06-18
- Earliest claimed: 2007-02-27
- Assignees: Miracor Medical SA
- Applicants: Miracor Medical SA
- Inventors: Werner Mohl
- Web page: https://patentgrep.com/patent/US20260168497A1

## CPC

- F04D 13/027: {Details of the magnetic circuit}
- A61M 60/13: by means of a catheter allowing explantation, e.g. catheter pumps temporarily introduced via the vascular system
- A61M 60/148: in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
- A61M 60/17: inside a ventricle, e.g. intraventricular balloon pumps
- A61M 60/237: the blood flow through the rotating member having mainly axial components, e.g. axial flow pumps
- A61M 60/405: the force acting on the blood contacting member being hydraulic or pneumatic
- A61M 60/419: the force acting on the blood contacting member being permanent magnetic, e.g. from a rotating magnetic coupling between driving and driven magnets
- A61M 60/422: the force acting on the blood contacting member being electromagnetic, e.g. using canned motor pumps
- A61M 60/523: using blood flow data, e.g. from blood flow transducers
- A61M 60/861: Connections or anchorings for connecting or anchoring pumps or pumping devices to parts of the patient's body
- A61M 60/414: transmitted by a rotating cable, e.g. for blood pumps mounted on a catheter
- A61M 60/833: Occluders for preventing backflow
- F04D: NON-POSITIVE-DISPLACEMENT PUMPS (engine fuel-injection pumps F02M; ion pumps H01J41/12; electrodynamic pumps H02K44/02)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A device to assist the performance of a heart with at least one pump that is formed as a rotary pump and magnetically driven.

## Claims

### Claim 1

A system for treating a heart, the system comprising:
a coronary occlusion catheter including a heart vessel occlusion balloon to occlude venous blood flow from a heart vessel into a right atrium;
an external control console connectable with the coronary occlusion catheter to selectively inflate the heart vessel occlusion balloon for occluding the heart vessel during an occlusion phase and to deflate the heart vessel occlusion balloon for substantially non-occluding the heart vessel during a release phase,
wherein the external control console includes: a controller configured to control the occlusion phase and the release phase, at least one sensor signal input to receive a hemodynamic sensor data signal from the coronary occlusion catheter, and a graphical user interface configured to simultaneously display a blood pressure numeric value, a heart rate numeric value, an occlusion phase time period, and a release phase time period,
wherein the controller is configured to randomly select a duration time for the release phase from a predefined bracketed range of about 2 seconds and about 15 seconds,
wherein the controller is configured to automatically deflate the heart vessel occlusion balloon in response to detecting a hemodynamic sensor signal above a threshold value,
wherein the external control console is configured to detect and store a series of local maxima or minima of the hemodynamic sensor data signal during the occlusion phase,
wherein the external control console is configured to execute a curve fit function representing an envelope curve for the series of local maxima or minima, and wherein the external control console is configured to determine a calculated release time for the occlusion phase based upon a time derivative of the curve fit function, and
wherein the external control console is configured to determine a weighted average time value that represents a point in time after a start of the occlusion phase and that is based upon the calculated release time and at least one previous release time value for at least one previous occlusion phase.

### Claim 2 (depends on 1)

The system of claim 1, wherein the external control console is configured to couple with a proximal portion of the coronary occlusion catheter, and the at least one sensor signal input of the external control console includes at least a pressure sensor signal input indicative of a blood pressure the heart vessel occlusion balloon.

### Claim 3 (depends on 2)

The system of claim 2, wherein the pressure sensor signal input is indicative of a coronary sinus pressure, and the external control console comprises a control circuit configured to activate a pneumatic subsystem to inflate the heart vessel occlusion balloon of the coronary occlusion catheter for a selected period of time based at least in part on the pressure sensor signal input indicative of the coronary sinus pressure.

### Claim 4 (depends on 3)

The system of claim 3, wherein the external control console is configured to detect and store a series of local maxima or minima of the pressure sensor signal input during the occlusion phase, generate a curve fit function representing an envelope curve for said series of local maxima or minima, and determine a calculated release time for the occlusion phase based upon a time derivative of the curve fit function.

### Claim 5 (depends on 1)

The system of claim 1, wherein the duration time for the release phase from the predetermined bracketed range comprises a time value from a predefined pattern of release phase duration times in the range about 2 seconds to about 6 seconds.

### Claim 6 (depends on 1)

The system of claim 1, wherein the external control console is configured to end the occlusion phase after a controlled occlusion phase time period that occurs over a series of heartbeats.

### Claim 7 (depends on 1)

The system of claim 1, wherein the sensor signal input of the external control console is configured to receive the hemodynamic sensor data signal during the occlusion phase, and the external control console further comprises a control circuit that activates a pneumatic subsystem to inflate the heart vessel occlusion balloon of the coronary occlusion catheter for a selected period of time based at least in part on the hemodynamic sensor data signal.

### Claim 8 (depends on 1)

The system of claim 1, wherein the heart vessel occlusion balloon comprises a distal conical balloon portion, a central cylindrical balloon portion, and a proximal conical balloon portion, and wherein the coronary occlusion catheter comprises a plurality of lumens extending to a distal portion of the coronary occlusion catheter that carries the heart vessel occlusion balloon, wherein the external control console is configured to selectively inflate the heart vessel occlusion balloon for a controlled duration to intermittently occlude venous blood flow from the heart vessel into the right atrium during the occlusion phase time period, and wherein the external control console comprises a display device configured to simultaneously display, during the occlusion phase time period, at least a graph of pressure measurements over time, the blood pressure numeric value, a heart rate numerical value, the occlusion phase time period, and the release phase time period.

### Claim 9 (depends on 1)

The system of claim 1, wherein the hemodynamic sensor data signal communicated to the external control console is indicative of a hemodynamic performance parameter selected from the group consisting of: coronary sinus pressure, fluid temperature in a coronary sinus, blood volume or mass flow rate in the coronary sinus, rate of change of the blood volume or the mass flow rate in the coronary sinus, acceleration of a vessel wall of the coronary sinus, displacement of a coronary sinus vessel, intra coronary sinus ECG, and contractility of the heart.

### Claim 10 (depends on 1)

The system of claim 1, wherein the heart vessel occlusion balloon is a coronary sinus occlusion balloon sized to occlude venous blood flow from a coronary sinus into the right atrium.

### Claim 11 (depends on 1)

system of claim 1, wherein the external control console houses: a pneumatic subsystem for delivery of an inflation fluid to the heart vessel occlusion balloon, and control circuitry that receives the hemodynamic sensor data signal and that triggers the pneumatic subsystem to deflate the heart vessel occlusion balloon in response to detecting the blood pressure measurement above the threshold value.

### Claim 12 (depends on 11)

The system of claim 11, wherein when the coronary occlusion catheter is connected to the external control console, the pneumatic subsystem of the external control console is in fluid communication with a balloon inflation lumen of the coronary occlusion catheter and the sensor signal input of the external control console is connected to a sensor line extending within the coronary occlusion catheter.

### Claim 13 (depends on 1)

The system of claim 1, wherein the graphic user interface of the external control console is configured to configured to simultaneously display at least a graph of arterial pressure as a function of time, the blood pressure numeric value, the heart rate numeric value, the occlusion phase time period, and the release phase time period.

### Claim 14 (depends on 1)

The system of claim 1, wherein the graphic user interface of the external control console is configured to display an alert in response to detecting the blood pressure measurement above the threshold value.

### Claim 15 (depends on 1)

The system of claim 1, wherein the external control console is configured to end the occlusion phase after a predefined occlusion phase time period according to a predetermined pattern of occlusion duration times and release duration times.

### Claim 16 (depends on 1)

The system of claim 1, wherein the external control console is configured to end the occlusion phase after a time period that occurs over a series of heartbeats.
